MetLife Declares Strong Dividend Amid Market Weakness
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 07 2025
0mins
Should l Buy MET?
MetLife Inc's stock has fallen 5.01% and hit a 5-day low amid a broader market decline, with the Nasdaq-100 down 1.28% and the S&P 500 down 1.01%.
Despite the market weakness, MetLife declared a semi-annual dividend of $29.375 per share, reflecting a strong yield of 74.76%. This announcement underscores the company's robust cash flow and commitment to shareholder returns, likely attracting increased investor interest. Additionally, MetLife's strategic goals include a target of $25 billion in free cash flow and anticipated double-digit adjusted EPS growth, highlighting its long-term growth potential.
The dividend declaration may provide some support to MetLife's stock price, as income-seeking investors often look for reliable dividend payers during market downturns.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MET?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MET
Wall Street analysts forecast MET stock price to rise
12 Analyst Rating
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 72.070
Low
84.00
Averages
95.25
High
108.00
Current: 72.070
Low
84.00
Averages
95.25
High
108.00
About MET
MetLife, Inc. is a financial services company, providing insurance, annuities, employee benefits and asset management to individual and institutional customers. Its segments include Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. Group Benefits segment offers life insurance, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment insurance, accident and health insurance, and vision, as well as prepaid legal plans and pet insurance. RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products. It operates across EMEA in both developed (Western Europe) and emerging (Central and Eastern Europe, Middle East and Africa) markets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
MetLife Issues $1 Billion Debentures Rated 'bbb+'
- Debt Issuance Size: MetLife has successfully issued $1 billion in subordinated debentures at a 5.85% interest rate, which is expected to be utilized for general business purposes, thereby enhancing the company's capital structure and supporting future business expansion.
- Stable Credit Rating: AM Best assigned a long-term credit rating of 'bbb+' to this debt issuance, indicating MetLife's robustness in the current market environment, while all other ratings remain unchanged, reflecting the company's overall financial health.
- Financial Leverage Situation: MetLife's proforma adjusted financial leverage and historical interest coverage align with its current ratings, demonstrating effective debt management that helps bolster investor confidence in the company's financial stability.
- Strong Liquidity: The holding company of MetLife exhibits strong liquidity, which secures its future financing activities and further solidifies its market position within the insurance industry.
See More
9 Robust Dividend Stocks as the Market Shifts Towards 'Tangible Assets'
- Investment Opportunities: The current market conditions favor dividend stocks, providing opportunities for income-seeking investors.
- Strategies for Investors: There are various strategies available for investors to capitalize on the potential growth of dividend stocks.
See More
Brighthouse Financial Agrees to Be Acquired for $70 per Share
- Acquisition Agreement: Brighthouse Financial has agreed to be acquired by Aquarian Capital for $70 per share in cash, with shareholders approving the deal, although it still requires final regulatory approval, highlighting the company's significance in the market.
- Market Performance Analysis: With the current stock price around $64, investors buying at this level could earn approximately 9% returns, reflecting optimistic market expectations for the acquisition and indicating the company's undervalued potential.
- Risk Assessment: If the acquisition fails to close as planned, Brighthouse Financial's stock could decline back to around $48, representing a 25% downside risk, which underscores the risk tolerance required from investors in this transaction.
- Investor Strategy Recommendation: Given the emotional and news-driven nature of the stock price, it is advised that only more aggressive investors participate in this trade, as strong confidence in the acquisition's completion is necessary to mitigate potential downside risks.
See More
MetLife Declares $29.375 Semi-Annual Dividend with Strong Yield
- Dividend Declaration: MetLife has declared a semi-annual dividend of $29.375 per share, reflecting a robust forward yield of 74.76%, which underscores the company's strong cash flow and commitment to shareholder returns, likely attracting increased investor interest.
- Preferred Stock Dividends: The company also announced a quarterly dividend of $351.5625 per share on its 5.625% Series E non-cumulative preferred stock and $296.875 per share on its 4.75% Series F non-cumulative preferred stock, enhancing the attractiveness of its preferred shares.
- Floating Rate Preferred Stock: Additionally, MetLife plans to declare a quarterly dividend of $0.31501229 per share on its floating-rate Series A preferred stock, pending confirmation of financial tests expected around March 5, 2026, indicating confidence in future financial stability.
- Strategic Goals: Through its New Frontier strategy, MetLife has set a target of $25 billion in free cash flow and anticipates double-digit adjusted EPS growth, highlighting the company's long-term growth potential in the market.
See More
MetLife Q4 2025 Earnings Call Highlights
- Strategic Progress: MetLife reported approximately $600 million in new adjusted premiums and revenues in 2025, reflecting a 10% year-over-year growth in its Group Benefits business, which strengthens its competitive position in a challenging market.
- Record Pension Risk Transfer Sales: The company achieved over $14 billion in pension risk transfer sales in 2025, marking significant growth in asset management, with year-end assets under management reaching $742 billion, highlighting strategic success in investment management.
- Shareholder Returns and Investments: MetLife returned about $2.9 billion to shareholders through stock repurchases and $1.5 billion in dividends in 2025, demonstrating its commitment to shareholder value while also investing approximately $1.2 billion in acquisitions and business development.
- Future Outlook and Targets: Management expects double-digit adjusted EPS growth in 2026, with adjusted ROE projected between 15% and 17%, indicating sustained growth potential and an enhanced market leadership position in the coming years.
See More
MetLife Reports Increased Fourth Quarter Profits Driven by Investment Returns
- Investment Income Growth: MetLife's net investment income reached $5.92 billion in Q4 2025, up from $5.41 billion a year earlier, driven by strong market performance following the Federal Reserve's rate cuts, thereby enhancing the company's overall profitability.
- Premium Revenue Surge: The company's adjusted premiums, fees, and other revenues rose by 29% to $18.61 billion in the quarter, reflecting robust consumer spending trends and disciplined premium pricing by insurers, which further fueled demand for policies.
- Increased Adjusted Earnings: MetLife reported adjusted earnings available to common shareholders of $1.65 billion, or $2.49 per share, significantly up from $1.46 billion and $2.09 per share a year prior, indicating a sustained improvement in profitability.
- Underperformance in Market: Despite strong performance in Q4 2025, the company's shares fell by 3.6% over the year, underperforming the broader market, reflecting concerns about its future growth potential.
See More
MetLife Issues $1 Billion Debentures Rated 'bbb+'
- Debt Issuance Size: MetLife has successfully issued $1 billion in subordinated debentures at a 5.85% interest rate, which is expected to be utilized for general business purposes, thereby enhancing the company's capital structure and supporting future business expansion.
- Stable Credit Rating: AM Best assigned a long-term credit rating of 'bbb+' to this debt issuance, indicating MetLife's robustness in the current market environment, while all other ratings remain unchanged, reflecting the company's overall financial health.
- Financial Leverage Situation: MetLife's proforma adjusted financial leverage and historical interest coverage align with its current ratings, demonstrating effective debt management that helps bolster investor confidence in the company's financial stability.
- Strong Liquidity: The holding company of MetLife exhibits strong liquidity, which secures its future financing activities and further solidifies its market position within the insurance industry.
See More
9 Robust Dividend Stocks as the Market Shifts Towards 'Tangible Assets'
- Investment Opportunities: The current market conditions favor dividend stocks, providing opportunities for income-seeking investors.
- Strategies for Investors: There are various strategies available for investors to capitalize on the potential growth of dividend stocks.
See More
Brighthouse Financial Agrees to Be Acquired for $70 per Share
- Acquisition Agreement: Brighthouse Financial has agreed to be acquired by Aquarian Capital for $70 per share in cash, with shareholders approving the deal, although it still requires final regulatory approval, highlighting the company's significance in the market.
- Market Performance Analysis: With the current stock price around $64, investors buying at this level could earn approximately 9% returns, reflecting optimistic market expectations for the acquisition and indicating the company's undervalued potential.
- Risk Assessment: If the acquisition fails to close as planned, Brighthouse Financial's stock could decline back to around $48, representing a 25% downside risk, which underscores the risk tolerance required from investors in this transaction.
- Investor Strategy Recommendation: Given the emotional and news-driven nature of the stock price, it is advised that only more aggressive investors participate in this trade, as strong confidence in the acquisition's completion is necessary to mitigate potential downside risks.
See More
MetLife Declares $29.375 Semi-Annual Dividend with Strong Yield
- Dividend Declaration: MetLife has declared a semi-annual dividend of $29.375 per share, reflecting a robust forward yield of 74.76%, which underscores the company's strong cash flow and commitment to shareholder returns, likely attracting increased investor interest.
- Preferred Stock Dividends: The company also announced a quarterly dividend of $351.5625 per share on its 5.625% Series E non-cumulative preferred stock and $296.875 per share on its 4.75% Series F non-cumulative preferred stock, enhancing the attractiveness of its preferred shares.
- Floating Rate Preferred Stock: Additionally, MetLife plans to declare a quarterly dividend of $0.31501229 per share on its floating-rate Series A preferred stock, pending confirmation of financial tests expected around March 5, 2026, indicating confidence in future financial stability.
- Strategic Goals: Through its New Frontier strategy, MetLife has set a target of $25 billion in free cash flow and anticipates double-digit adjusted EPS growth, highlighting the company's long-term growth potential in the market.
See More
MetLife Q4 2025 Earnings Call Highlights
- Strategic Progress: MetLife reported approximately $600 million in new adjusted premiums and revenues in 2025, reflecting a 10% year-over-year growth in its Group Benefits business, which strengthens its competitive position in a challenging market.
- Record Pension Risk Transfer Sales: The company achieved over $14 billion in pension risk transfer sales in 2025, marking significant growth in asset management, with year-end assets under management reaching $742 billion, highlighting strategic success in investment management.
- Shareholder Returns and Investments: MetLife returned about $2.9 billion to shareholders through stock repurchases and $1.5 billion in dividends in 2025, demonstrating its commitment to shareholder value while also investing approximately $1.2 billion in acquisitions and business development.
- Future Outlook and Targets: Management expects double-digit adjusted EPS growth in 2026, with adjusted ROE projected between 15% and 17%, indicating sustained growth potential and an enhanced market leadership position in the coming years.
See More
MetLife Reports Increased Fourth Quarter Profits Driven by Investment Returns
- Investment Income Growth: MetLife's net investment income reached $5.92 billion in Q4 2025, up from $5.41 billion a year earlier, driven by strong market performance following the Federal Reserve's rate cuts, thereby enhancing the company's overall profitability.
- Premium Revenue Surge: The company's adjusted premiums, fees, and other revenues rose by 29% to $18.61 billion in the quarter, reflecting robust consumer spending trends and disciplined premium pricing by insurers, which further fueled demand for policies.
- Increased Adjusted Earnings: MetLife reported adjusted earnings available to common shareholders of $1.65 billion, or $2.49 per share, significantly up from $1.46 billion and $2.09 per share a year prior, indicating a sustained improvement in profitability.
- Underperformance in Market: Despite strong performance in Q4 2025, the company's shares fell by 3.6% over the year, underperforming the broader market, reflecting concerns about its future growth potential.
See More
